This statistic depicts the overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022. As of that year, GlaxoSmithKline - with 4.06 - had the highest total score. The Access to Medicine Index is an independent initiative that ranks the world’s
20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022
The Access to Medicine Index is an independent
initiative that ranks the world’s
20 largest companies according to their
efforts to make their products more available,
affordable and accessible in developing
countries, highlighting policy and
practice that either facilitate or hinder
access to medicine.
The Index uses a framework that evaluates
company activities in seven areas of activity,
or technical areas, considered to be key to
enhancing access to medicine in developing
countries, and across four important aspects
of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Merck & Co., Inc. is known as MSD outside
the US and Canada. Merck KGaA’s
healthcare division is known as EMD
Serono in the US and Canada.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Access to Medicine Index. (November 15, 2022). Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022 [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/
Access to Medicine Index. "Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022." Chart. November 15, 2022. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/
Access to Medicine Index. (2022). Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022. Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/
Access to Medicine Index. "Overall Pharmaceutical Company Ranking of The Access to Medicine Index for Developing Countries as of 2022." Statista, Statista Inc., 15 Nov 2022, https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/
Access to Medicine Index, Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022 Statista, https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/ (last visited July 22, 2024)
Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries as of 2022 [Graph], Access to Medicine Index, November 15, 2022. [Online]. Available: https://www.statista.com/statistics/250425/worldwide-overall-ranking-of-the-access-to-medicine-index-2016/
